Aspirin, 2-Acetoxybenzoic acid, has been widely used for its ability to treat pain, migraines, fever, inflammation, and cardiovascular diseases. In the acidic medium of human stomach, aspirin is dissociated rapidly and causes a stomach irritation, ulcer, and stomach and intestine bleeding, especially in elderly people. The rapid dissociation of aspirin in human stomach leads to a significant loss in its original dose that is supposed to be absorbed in small intestines, where the maximum absorption of medicines occurs. Based on the superior chemical and physical properties of hydrogels in absorption and retention the aqueous solutions of medicines, a natural hydrogel was prepared, and its ability in reducing the rapid release and loss of aspirin in conditions similar to human stomach; pH=2 and temperature=37 °C. Our results showed that the addition of hydrogel to an aqueous solution of aspirin has reduced the amount of lost aspirin. The correlation analysis between the concentration of retained aspirin and the amount of hydrogel was significant P < 0.05. The maximum obtained retention ratio to aspirin was 60%, which was achieved with 1:2 w/w of aspirin /hydrogel. The retention ability of hydrogel has led to decrease the loss in aspirin due to its rapid release in the acidic medium of stomach and consequently increase absorbed aspirin in the small intestines. The hydrogel was made from natural products by using a green method; therefore, the ability of gel to reduce aspirin releasing levels in stomach, increase the retention to aspirin, and the therapeutic activity of aspirin with the hydrogel should be tested on patients.

1.
L.
Brannon-Peppas
,
Preparation and characterization of crosslinked hydrophilic networks
.
Studies in polymer science.
8
,
45
66
(
1990
).
2.
M.
Sadeghi
and
F.
Soleimani
.
Synthesis and characterization superabsorbent hydrogelsfor oral drug delivery systems
.
Int J Chem Eng App.
5
,
314
316
(
2011
).
3.
N. A.
Peppas
and
N. K.
Mongia
.
Ultrapure poly (vinyl alcohol) hydrogels with mucoadhesive drug delivery characteristics
.
Eur J Pharm Biopharm.
1
,
51
58
(
1997
).
4.
N. A.
Peppas
,
P.
Bures
,
W.
Leobandung
,
H.
Ichikawa
.
Hydrogels in pharmaceutical formulations
.
Eur J Pharm Biopharm.
1
,
27
46
(
2000
).
5.
Y.
Qiu
and
K.
Park
.
Environment-sensitive hydrogels for drug delivery
.
Adv Drug Deliv Rev.
64
,
49
60
(
2012
).
6.
E. H.
Awtry
and
J.
Loscalzo
.
Aspirin. Circulation.
10
,
1206
1218
(
2000
).
7.
C.
Patrono
,
L. A.
García Rodríguez
,
R.
Landolfi
,
C.
Baigent
.
Low-dose aspirin for the prevention of atherothrombosis
.
N Engl J Med.
22
,
2373
2383
(
2005
).
8.
M. J.
Thun
,
M. M.
Namboodiri
,
C. W.
Heath
 Jr.
Aspirin use and reduced risk of fatal colon cancer
.
N Engl J Med.
23
,
1593
1596
(
1991
).
9.
P. M.
Rothwell
,
M.
Wilson
,
C. E.
Elwin
,
B.
Norrving
,
A.
Algra
,
C. P.
Warlow
,
T. W.
Meade
.
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomized trials
.
The Lancet.
9754
,
1741
1750
(
2010
).
10.
P. M.
Rothwell
,
F. G. R.
Fowkes
,
J. F.
Belch
,
H.
Ogawa
,
C. P.
Warlow
,
T. W.
Meade
.
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomized trials
.
The Lancet.
9759
,
31
41
(
2011
).
11.
T. D.
Warner
and
J. A.
Mitchell
.
Proceedings of the National Academy of Sciences of the United States of America
.;
WHO Model List of Essential Medicines (19th List)
.
21
,
13371
13373
(
2002
).
12.
J. R.
Vane
and
R. M.
Botting
.
The mechanism of action of aspirin
.
Thromb Res.
5-6
,
255
258
(
2003
).
13.
J. L.
Wallace
.
Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself
.
Physiol Rev.
4
,
1547
1565
(
2008
).
14.
A.
Lanas
,
E.
Bajador
,
P.
Serrano
,
J.
Fuentes
,
S.
Carreño
,
J.
Guardia
,
M.
Sanz
,
M.
Montoro
,
R.
Sáinz
.
Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding
.
N Engl J Med.
12
,
834
839
(
2000
).
15.
F. K.
Chan
,
S. S.
Chung
,
B. Y.
Suen
,
Y. T.
Lee
,
W. K.
Leung
,
V. K.
Leung
,
J. C.
Wu
,
J. Y.
Lau
,
Y.
Hui
,
M. S.
Lai
,
H. L.
Chan
,
J. J.
Sung
.
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen
.
N Engl J Med.
13
,
967
973
(
2001
).
16.
J.
Weil
,
D.
Colin-Jones
,
M.
Langman
,
D.
Lawson
,
R.
Logan
,
M.
Murphy
,
M.
Rawlins
,
M.
Vessey
,
P.
Wainwright
.
Prophylactic aspirin and risk of peptic ulcer bleeding
.
BMJ.
6983
,
827
830
(
1995
).
17.
A. G.
Pinkus
. U.S. Patent No. 6,280,772. (
2001
).
18.
F.
Soleimani
,
M.
Sadeghi
.
Synthesis of pH-sensitive hydrogel based on starch-polyacrylate superabsorbent
.
JBNB.
2A
,
310
314
(
2012
).
19.
A. K. H.
Al-Khalaf
and
F. H.
Hussein
, “Green and sustainable advanced nanomaterials, in: Green and sustainable advanced materials: processing and characterization”.
Wiley Online Library
,
John Wiley & Sons, Inc
. Vol.
1
, pp.
93
106
(
2018
).
20.
A.
Hadi
.
Synthesis of chitosan and its use in metal removal
.
J Chem Mat Res.
3
,
22
26
(
2013
).
This content is only available via PDF.